Theories on the Mechanism of Action of Ketamine: From NMDA Receptor Inhibition to the (2R, 6R)-HNK Metabolite

被引：0
|
作者：
Zarate, Carlos [1 ]
Gould, Todd [2 ]
Zanos, Panos [2 ]
Machado-Vieira, Rodrigo [1 ]
机构：
[1] NIMH, Bethesda, MD USA
[2] Univ Maryland Baltimore, Baltimore, MD USA
来源：
BIOLOGICAL PSYCHIATRY | 2017年 / 81卷 / 10期
关键词：
AMPA; Ketamine; NMDA Receptor; Metabolism; mechanism of action;
D O I：
10.1016/j.biopsych.2017.02.092
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
80
引用
收藏
页码：S33 / S34
页数：2
相关论文
共 50 条
  • [1] Kinetic mechanism of NMDA receptor inhibition by the ketamine metabolite 2R,6R-hydroxynorketamine
    Raymond, Faye
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 396A - 396A
  • [2] Analgesic and Antinociceptive Effects of the Ketamine Metabolite (2R,6R)-Hydroxynorketamine (HNK) in Mice
    Yost, Jonathan
    Browne, Caroline
    Lucki, Irwin
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 271 - 271
  • [3] Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
    Lumsden, Eric W.
    Troppoli, Timothy A.
    Myers, Scott J.
    Zanos, Panos
    Aracava, Yasco
    Kehr, Jan
    Lovett, Jacqueline
    Kim, Sukhan
    Wang, Fu-Hua
    Schmidt, Staffan
    Jenne, Carleigh E.
    Yuan, Peixiong
    Morris, Patrick J.
    Thomas, Craig J.
    Zarate, Carlos A., Jr.
    Moaddel, Ruin
    Traynelis, Stephen F.
    Pereira, Edna F. R.
    Thompson, Scott M.
    Albuquerque, Edson X.
    Gould, Todd D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (11) : 5160 - 5169
  • [4] Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors
    Joseph, Thomas T.
    Bu, Weiming
    Lin, Wenzhen
    Zoubak, Lioudmila
    Yeliseev, Alexei
    Liu, Renyu
    Eckenhoff, Roderic G.
    Brannigan, Grace
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (09): : 1487 - 1497
  • [5] Mechanism of Antidepressant Action of (2R,6R)-6-Hydroxynorketamine (HNK) and Its Compounds: Insights from Proteomic Analysis
    Chaohui Zhen
    Chong Wang
    Yanjun Ma
    Yuli Pang
    Feiyue Cai
    Jiali Meng
    Yuefei He
    Ping Xiao
    Jianxi Liu
    Xi Mei
    Shupeng Li
    Guanzheng Wu
    Guangzhen Jin
    Biao Zheng
    Rui Liang
    Zhen Tan
    Molecular Neurobiology, 2024, 61 (1) : 465 - 475
  • [6] Mechanism of Antidepressant Action of (2R,6R)-6-Hydroxynorketamine (HNK) and Its Compounds: Insights from Proteomic Analysis
    Zhen, Chaohui
    Wang, Chong
    Ma, Yanjun
    Pang, Yuli
    Cai, Feiyue
    Meng, Jiali
    He, Yuefei
    Xiao, Ping
    Liu, Jianxi
    Mei, Xi
    Li, Shupeng
    Wu, Guanzheng
    Jin, Guangzhen
    Zheng, Biao
    Liang, Rui
    Tan, Zhen
    MOLECULAR NEUROBIOLOGY, 2024, 61 (01) : 465 - 475
  • [7] Efficacy of the ketamine metabolite (2R, 6R)-hydroxynorketamine in mice models of pain
    Kroin, Jeffrey S.
    Das, Vaskar
    Moric, Mario
    Buvanendran, Asokumar
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2019, 44 (01) : 111 - 117
  • [8] Analgesic and Antinociceptive Effects of (2R, 6R)-hydroxynorketamine (HNK) in Mice
    Yost, Jonathan G.
    Browne, Caroline A.
    Lucki, Irwin
    FASEB JOURNAL, 2022, 36
  • [9] Ketamine Increases vmPFC Activity: Effects of (R)- and (S)-Stereoisomers and (2R,6R) Hydroxynorketamine Metabolite
    Hare, Brendan
    Pothula, Santosh
    DiLeone, Ralph
    Duman, Ronald
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S191 - S191
  • [10] Ketamine increases vmPFC activity: Effects of (R)- and (S)-stereoisomers and (2R, 6R)-hydroxynorketamine metabolite
    Hare, Brendan D.
    Pothula, Santosh
    DiLeone, Ralph J.
    Duman, Ronald S.
    NEUROPHARMACOLOGY, 2020, 166
12345